Does B12 deficiency lead to lack of treatment response to conventional antidepressants?

Ms. Kate is Junior Resident is from the Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Psychiatry 11/2010; 7(11):42-4.
Source: PubMed


We present two cases of treatment-resistant depression that improved with recognition and correction of the underlying medical etiology of vitamin B12 deficiency. Supplementations of vitamin B12 to the same antidepressant regimen that the patient had not responded earlier led to response. Two male subjects who were vegetarians presented with long-standing histories of depression and had not responded to three adequate trials of antidepressants. Upon investigation, the authors found that the subjects had low vitamin B12 levels. Both cases improved with supplementation of vitamin B12. Subjects with depression who do not respond to conventional antidepressants should be evaluated for nutritional factors.

Download full-text


Available from: Natasha Kate, Sep 28, 2014

Click to see the full-text of:

Article: Does B12 deficiency lead to lack of treatment response to conventional antidepressants?

83.55 KB

See full-text
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Vitamin B12, cyanocobalamin, is implicated in metabolic and neurotrophic functions. Its deficiency is associated with hematological, neurological and psychiatric disorders. Herein we report the case of a patient presenting with refractory depression who improved after the identification and treatment of vitamin B12 deficiency. This report highlights the relevance of considering secondary causes of depression in refractory cases.
    Jornal brasileiro de psiquiatria 12/2010; 60(2):141-143. DOI:10.1590/S0047-20852011000200010
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Ali Akhondpour Manteghi , Roya Samadi , Parisa Samadi Abstract: Introduction:Megaloblastic anemias are group of disorders that usually are caused by deficiency of vitamin B12 or folate. Vitamin B12 deficiency occurs with a wide range of symptoms of hematology، neurology، gastrointestinal or psychiatry. Untreated anemia prevents the appropriate treatment even if the patient be treated properly for psychiatric disorder، will be often having inadequate response or resistance to treatment. Materials and Methods: This paper presents a 33 years old woman who had experienced depression and mood lability and had been under psychiatric treatment with various psychiatric diagnoses such as borderline personality disorder، major depressive disorder and mood disorder NOS. During the six month before admission balance impairment، paresthesia، coldness and pain in lower limbs was gradually added to her symptoms. She was admitted to psychiatric hospital as a result of her suicidal thoughts and function disturbances. Complete blood count and serum B12 and folic acid levels were performed with suspicion to megaloblastic anemia. Following confirmation of diagnosis (low serum B12:90 pg ml) and treatment onset، symptoms disappeared dramatically within a few days. Patient was discharged from psychiatric hospital and in order to determine causes of megaloblastic anemia she was referred to an internist. Conclusion:Mental disorders are prevalent in cobalamin deficiency، so even in the absence of anemia or neurological symptoms of B12 deficiency، probability of megaloblastic anemia should be considered in atypical symptoms or psychiatric disorders، refractory to conventional treatments، fluctuating and uncommon symptoms. Keywords:Depression, Megaloblastic anemia, Vitamin B12
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The single infusion of ketamine, an N-methyl-d-aspartic acid (NMDA) glutamate receptor antagonist, exerts a therapeutic effect in both unipolar and bipolar depression. Homocysteine (HCY) acts agonistically on the NMDA receptor, hyperhomocysteinemia is related to depression, and folic acid and vitamin B12 are associated with HCY system. We estimated the serum levels of these substances in 20 bipolar depressed patients before ketamine infusion. 10 patients responded favorably to this procedure, as their score on the Hamilton depression rating scale, compared to baseline, was reduced by more than 50%, after 7 days. The vitamin B12 level was significantly higher in "responders" compared to the remaining patients. No differences between the 2 groups were found with regard to HCY, folic acid levels and such clinical factors as age, duration of illness and duration of current episode. These preliminary data suggest that the vitamin B12 level may be connected with the efficacy of ketamine infusion in bipolar depression.
    Pharmacopsychiatry 07/2013; 46(6). DOI:10.1055/s-0033-1349861 · 1.85 Impact Factor
Show more